Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
JAMA Cardiology
|
November 3, 2021
Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial
Douglas L Mann, Michael M Givertz, Justin M Vader, et al.
JAMA
|
May 17, 2017
Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial
Gregory D Lewis, Rajeev Malhotra, Adrian F Hernandez, et al.
JACC. Heart Failure
|
July 10, 2020
Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial
Douglas L Mann, Stephen J Greene, Michael M Givertz, et al.
The New England Journal of Medicine
|
November 10, 2015
Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction
Margaret M Redfield, Kevin J Anstrom, James A Levine, et al.
The New England Journal of Medicine
|
March 4, 2011
Diuretic strategies in patients with acute decompensated heart failure
G Michael Felker, Kerry L Lee, David A Bull, et al.
Circulation
|
May 20, 2015
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study
Michael M Givertz, Kevin J Anstrom, Margaret M Redfield, et al.
The New England Journal of Medicine
|
November 8, 2012
Ultrafiltration in decompensated heart failure with cardiorenal syndrome
Bradley A Bart, Steven R Goldsmith, Kerry L Lee, et al.
JAMA
|
March 13, 2013
Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial
Margaret M Redfield, Horng H Chen, Barry A Borlaug, et al.
JAMA
|
November 20, 2013
Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial
Horng H Chen, Kevin J Anstrom, Michael M Givertz, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 29, 2022
Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19
Jane A O'Halloran, Eyal Kedar, Kevin J Anstrom, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
JAMA Cardiology
|
November 3, 2021
Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial
Douglas L Mann, Michael M Givertz, Justin M Vader, et al.
JAMA
|
May 17, 2017
Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial
Gregory D Lewis, Rajeev Malhotra, Adrian F Hernandez, et al.
JACC. Heart Failure
|
July 10, 2020
Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial
Douglas L Mann, Stephen J Greene, Michael M Givertz, et al.
The New England Journal of Medicine
|
November 10, 2015
Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction
Margaret M Redfield, Kevin J Anstrom, James A Levine, et al.
The New England Journal of Medicine
|
March 4, 2011
Diuretic strategies in patients with acute decompensated heart failure
G Michael Felker, Kerry L Lee, David A Bull, et al.
Circulation
|
May 20, 2015
Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study
Michael M Givertz, Kevin J Anstrom, Margaret M Redfield, et al.
The New England Journal of Medicine
|
November 8, 2012
Ultrafiltration in decompensated heart failure with cardiorenal syndrome
Bradley A Bart, Steven R Goldsmith, Kerry L Lee, et al.
JAMA
|
March 13, 2013
Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial
Margaret M Redfield, Horng H Chen, Barry A Borlaug, et al.
JAMA
|
November 20, 2013
Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial
Horng H Chen, Kevin J Anstrom, Michael M Givertz, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 29, 2022
Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19
Jane A O'Halloran, Eyal Kedar, Kevin J Anstrom, et al.
Page
of 4